Heinz Feldmann

Heinz Feldmann Heinz (Heinrich) Ulrich Feldmann is a German-American virologist who currently serves as the chief of the laboratory of virology at Rocky Mountain Laboratories, NIAID and heads the Disease Modelling and Transmission section. His research focuses on highly pathogenic viruses that require strict biocontainment, including those that cause viral hemorrhagic fever such as Ebola and Lassa. He has been responsible for the development of timely viral countermeasures including the rVSV-ZEBOV vaccine (Ervebro), development of vaccines and drugs against SARS-CoV-2, and epidemiology of SARS-CoV. Provided by Wikipedia
Showing 1 - 20 results of 111 for search 'Heinz Feldmann', query time: 0.17s Refine Results
  1. 1
    Recent advances in understanding Crimean–Congo hemorrhagic fever virus [version 1; referees: 4 approved]
    by David W. Hawman, Heinz Feldmann
    Published 2018-10-01
    Get full text
    Article
  2. 2
    Cathepsin B & L are not required for ebola virus replication.
    by Andrea Marzi, Thomas Reinheckel, Heinz Feldmann
    Published 2012-01-01
    Get full text
    Article
  3. 3
    Kyasanur Forest Disease and Alkhurma Hemorrhagic Fever Virus—Two Neglected Zoonotic Pathogens
    by Bharti Bhatia, Heinz Feldmann, Andrea Marzi
    Published 2020-09-01
    Get full text
    Article
  4. 4
    Effective Chemical Inactivation of Ebola Virus
    Get full text
    Article
  5. 5
    Animal Models of Tick-Borne Hemorrhagic Fever Viruses
    by Heinz Feldmann, David Safronetz, Marko Zivcec
    Published 2013-05-01
    Get full text
    Article
  6. 6
    Ebola Conquers West Africa — More to Come?
    Get full text
    Article
  7. 7
    A Look into <i>Bunyavirales </i>Genomes: Functions of Non-Structural (NS) Proteins
    Get full text
    Article
  8. 8
    Lassa Virus Treatment Options
    Get full text
    Article
  9. 9
    Long-Term Single-Dose Efficacy of a Vesicular Stomatitis Virus-Based Andes Virus Vaccine in Syrian Hamsters
    Get full text
    Article
  10. 10
    In vitro and in vivo activity of ribavirin against Andes virus infection.
    Get full text
    Article
  11. 11
    Ebola Virus Glycoprotein Domains Associated with Protective Efficacy
    Get full text
    Article
  12. 12
    Antiviral Innate Responses Induced by VSV-EBOV Vaccination Contribute to Rapid Protection
    Get full text
    Article
  13. 13
    Transcriptomic analysis reveals a previously unknown role for CD8+ T-cells in rVSV-EBOV mediated protection
    Get full text
    Article
  14. 14
    Vesicular Stomatitis Virus–Based Vaccines against Lassa and Ebola Viruses
    Get full text
    Article
  15. 15
    Nucleocapsid protein-based vaccine provides protection in mice against lethal Crimean-Congo hemorrhagic fever virus challenge.
    Get full text
    Article
  16. 16
    An Intramuscular DNA Vaccine for SARS-CoV-2 Decreases Viral Lung Load but Not Lung Pathology in Syrian Hamsters
    Get full text
    Article
  17. 17
    Nipah virus transmission in a hamster model.
    Get full text
    Article
  18. 18
    Experimental Andes virus infection in deer mice: characteristics of infection and clearance in a heterologous rodent host.
    Get full text
    Article
  19. 19
    Delayed Disease Progression in Cynomolgus Macaques Infected with Ebola Virus Makona Strain
    Get full text
    Article
  20. 20
    Lack of Protection Against Ebola Virus from Chloroquine in Mice and Hamsters
    Get full text
    Article
Search Tools: Get RSS Feed — Email this Search